Lizhu Lin

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · The Lancet Respiratory Medicine · 2020 · 488 citations

Oncology, Clinical Trials, Chemotherapy-naive Patients +9

Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts.

Lizhu Lin, Alice Lin, David L. DeWitt · Journal of Biological Chemistry · 1992 · 232 citations · Full text

Inflammatory Lung Disease, Immunology, Pathology +24

Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2.

Takashi Nakamura, Lizhu Lin, Surender Kharbanda et al. · The EMBO Journal · 1992 · 113 citations · Full text

Proteinlipid Interaction, Macrophage Colony, Signal Transduction +13

The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells

Qian Zuo, Renyi Wu, Xi Xiao et al. · Journal of Cellular Biochemistry · 2018 · 94 citations

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 65 citations · Full text

Advanced Nonsquamous Nsclc, Oncology, Camrelizumab Plus Carboplatin +9